USFDA inspects granules facility

Published on March 17, 2015 14:08:25 PM
The US Food and Drug Administration had inspected Granules India’s Gagillapur manufacturing facility near Hyderabad and did not find any deviation from good manufacturing norms.

The inspection was triggered by one of the applicant's Abbreviated New Drug Application filing.